+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Colas SA - Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 40 Pages
  • July 2026
  • GlobalData
  • Colas Group
  • ID: 1495046
Colas SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - The analyst’s summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

Colas SA (Colas), a subsidiary of Bouygues Group, is a construction contractor. It provides construction and maintenance services for transport infrastructure, urban development and recreational facilities. The company’s portfolio of services includes construction and management of highways, roads, runways, ports, reserved-lane public transport, logistics hubs, bike paths, industrial platforms, motor racing circuits, recreational amenities, and environmental projects. It also provides civil engineering services and specializes in the production and recycling of construction materials. Colas’ specialized activities business includes railways, waterproofing, sales of refined products, road safety and signaling, and networks. It has market presence in several countries across Asia, Africa, Europe, the Middle East and North America. Colas is headquartered in Paris, Ile-de-France, France.

Colas SA Key Recent Developments

  • Jun 11, 2026: Continental Bitumen Subsidiary Specialising in Bitumen
  • Jun 11, 2026: Bitumen Production and Distribution
  • Jun 11, 2026: Spac Water and Energy Transportation Activity
  • Jun 11, 2026: Tersen Company Specialising in Public Works and the Environment

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with the analyst’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • Sartorius Stedim Biotech SA - Key Facts
  • Sartorius Stedim Biotech SA - Key Employees
  • Sartorius Stedim Biotech SA - Key Employee Biographies
  • Sartorius Stedim Biotech SA - Major Products and Services
  • Sartorius Stedim Biotech SA - History
  • Sartorius Stedim Biotech SA - Company Statement
  • Sartorius Stedim Biotech SA - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Sartorius Stedim Biotech SA - Business Description
  • Geographical Segment: Americas
  • Performance
  • Geographical Segment: Asia Pacific
  • Performance
  • Geographical Segment: EMEA
  • Performance
  • R&D Overview
  • Sartorius Stedim Biotech SA - Corporate Strategy
  • Sartorius Stedim Biotech SA - SWOT Analysis
  • SWOT Analysis - Overview
  • Sartorius Stedim Biotech SA - Strengths
  • Sartorius Stedim Biotech SA - Weaknesses
  • Sartorius Stedim Biotech SA - Opportunities
  • Sartorius Stedim Biotech SA - Threats
  • Sartorius Stedim Biotech SA - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • Sartorius Stedim Biotech SA, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 21, 2026: Sartorius Opens Competence Center for Cell and Gene Therapy Components in Freiburg
  • Apr 23, 2026: Sartorius Stedim Biotech Reports Strong Q1 2026 Results
  • Mar 24, 2026: Mixed General Meeting Resolutions of Sartorius Stedim Biotech S.A.
  • Mar 17, 2026: Sartorius Sharpens Strategy With Biopharma Focus, Sets New Mid-Term Growth Targets
  • Feb 03, 2026: Sartorius Stedim Biotech Achieves Considerable Profitable Growth in 2025 and Maintains Positive Outlook
  • Jul 29, 2025: Bio Usawa Biotechnology and Sartorius Stedim Biotech Enter Into Partnership
  • Jul 09, 2025: Sartorius Stedim Biotech and Sensible Biotechnologies Sign Memorandum of Understanding
  • Jun 17, 2025: Sartorius expands manufacturing and R&D capacities for innovative bioprocess solutions in France
  • Feb 17, 2025: Sartorius Releases Annual Report Financial Results for 2024 Read Media Release
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Sartorius Stedim Biotech SA, Key Facts
  • Sartorius Stedim Biotech SA, Key Employees
  • Sartorius Stedim Biotech SA, Key Employee Biographies
  • Sartorius Stedim Biotech SA, Major Products and Services
  • Sartorius Stedim Biotech SA, History
  • Sartorius Stedim Biotech SA, Subsidiaries
  • Sartorius Stedim Biotech SA, Key Competitors
  • Sartorius Stedim Biotech SA, Ratios based on current share price
  • Sartorius Stedim Biotech SA, Annual Ratios
  • Sartorius Stedim Biotech SA, Interim Ratios
  • Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • Sartorius Stedim Biotech SA, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Sartorius Stedim Biotech SA, Performance Chart (2021 - 2025)
  • Sartorius Stedim Biotech SA, Ratio Charts
  • Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026